Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Golden Meditech Raises $34.7 Million in Taiwan

publication date: Jan 24, 2011
Golden Meditech Holdings raised $34.7 million by listing 90 million Depositary Receipts on the Taiwan Stock Exchange. Each unit consists of two shares of Golden Meditech’s Hong Kong-listed stock. The Depository Receipts were priced at a slight discount to the Hong Kong shares, but triggered the Taiwan exchange’s 7% upper limit after they began trading. Golden Meditech, which is based in Hong Kong, has its operations in mainland China. More details....

Stock Symbols: (HK: 801) (TSE: 910801)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital